Search research articles
Contact Us
Filters
Showing results (101-110 of 130) with videos related to
Page
of 13
Sort By:
Psychopharmacology Bulletin
|
January 1, 1984
Cholecystokinin octapeptide in dementia
M Serby, B Angrist, J Corwin, et al.
Psychopharmacology
|
January 1, 1987
Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography
A Wolkin, B Angrist, A Wolf, et al.
Psychiatry Research
|
May 1, 1991
Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia
E J Bartlett, F Barouche, J D Brodie, et al.
Life Sciences
|
December 27, 1982
Red cell phospholipids in schizophrenia
A Lautin, D M Cordasco, D J Segarnick, et al.
Neurobiology of Aging
|
January 1, 1985
Conformational changes in muscarinic receptors may produce diminished cholinergic neurotransmission and memory deficits in aged rats
A S Lippa, C C Loullis, J Rotrosen, et al.
The American Journal of Psychiatry
|
February 1, 1988
Low frontal glucose utilization in chronic schizophrenia: a replication study
A Wolkin, B Angrist, A Wolf, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
November 1, 1979
Neuroendocrine effects of apomorphine: characterization of response patterns and application to schizophrenia research
J Rotrosen, B Angrist, S Gershon, et al.
Psychoneuroendocrinology
|
May 22, 2014
Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype
O Levran, E Peles, M Randesi, et al.
Archives of General Psychiatry
|
May 12, 2000
Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms
M Sanfilipo, T Lafargue, H Rusinek, et al.
Biological Psychiatry
|
November 1, 1993
Elevated PLA2 activity in schizophrenics and other psychiatric patients
M Noponen, M Sanfilipo, K Samanich, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 130) with videos related to
Sort By:
Page
of 13
Psychopharmacology Bulletin
|
January 1, 1984
Cholecystokinin octapeptide in dementia
M Serby, B Angrist, J Corwin, et al.
Psychopharmacology
|
January 1, 1987
Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography
A Wolkin, B Angrist, A Wolf, et al.
Psychiatry Research
|
May 1, 1991
Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia
E J Bartlett, F Barouche, J D Brodie, et al.
Life Sciences
|
December 27, 1982
Red cell phospholipids in schizophrenia
A Lautin, D M Cordasco, D J Segarnick, et al.
Neurobiology of Aging
|
January 1, 1985
Conformational changes in muscarinic receptors may produce diminished cholinergic neurotransmission and memory deficits in aged rats
A S Lippa, C C Loullis, J Rotrosen, et al.
The American Journal of Psychiatry
|
February 1, 1988
Low frontal glucose utilization in chronic schizophrenia: a replication study
A Wolkin, B Angrist, A Wolf, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
November 1, 1979
Neuroendocrine effects of apomorphine: characterization of response patterns and application to schizophrenia research
J Rotrosen, B Angrist, S Gershon, et al.
Psychoneuroendocrinology
|
May 22, 2014
Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype
O Levran, E Peles, M Randesi, et al.
Archives of General Psychiatry
|
May 12, 2000
Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms
M Sanfilipo, T Lafargue, H Rusinek, et al.
Biological Psychiatry
|
November 1, 1993
Elevated PLA2 activity in schizophrenics and other psychiatric patients
M Noponen, M Sanfilipo, K Samanich, et al.
Page
of 13